These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

310 related items for PubMed ID: 10566625

  • 21. Endocrine effects of oral dehydroepiandrosterone in men with HIV infection: a prospective, randomized, double-blind, placebo-controlled trial.
    Poretsky L, Brillon DJ, Ferrando S, Chiu J, McElhiney M, Ferenczi A, Sison MC, Haller I, Rabkin J.
    Metabolism; 2006 Jul; 55(7):858-70. PubMed ID: 16784956
    [Abstract] [Full Text] [Related]

  • 22. Supplementation with DHEA: effect on muscle size, strength, quality of life, and lipids.
    Dayal M, Sammel MD, Zhao J, Hummel AC, Vandenbourne K, Barnhart KT.
    J Womens Health (Larchmt); 2005 Jun; 14(5):391-400. PubMed ID: 15989411
    [Abstract] [Full Text] [Related]

  • 23. Effects of dehydroepiandrosterone (DHEA) on cardiovascular risk factors in older women with frailty characteristics.
    Boxer RS, Kleppinger A, Brindisi J, Feinn R, Burleson JA, Kenny AM.
    Age Ageing; 2010 Jul; 39(4):451-8. PubMed ID: 20484057
    [Abstract] [Full Text] [Related]

  • 24. Dehydroepiandrosterone replacement in healthy men with age-related decline of DHEA-S: effects on fat distribution, insulin sensitivity and lipid metabolism.
    Jedrzejuk D, Medras M, Milewicz A, Demissie M.
    Aging Male; 2003 Sep; 6(3):151-6. PubMed ID: 14628495
    [Abstract] [Full Text] [Related]

  • 25. Dehydroepiandrosterone replacement administration: pharmacokinetic and pharmacodynamic studies in healthy elderly subjects.
    Legrain S, Massien C, Lahlou N, Roger M, Debuire B, Diquet B, Chatellier G, Azizi M, Faucounau V, Porchet H, Forette F, Baulieu EE.
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3208-17. PubMed ID: 10999810
    [Abstract] [Full Text] [Related]

  • 26. DHEA treatment for HIV+ patients: effects on mood, androgenic and anabolic parameters.
    Rabkin JG, Ferrando SJ, Wagner GJ, Rabkin R.
    Psychoneuroendocrinology; 2000 Jan; 25(1):53-68. PubMed ID: 10633535
    [Abstract] [Full Text] [Related]

  • 27. Low serum levels of sex steroids are associated with disease characteristics in primary Sjogren's syndrome; supplementation with dehydroepiandrosterone restores the concentrations.
    Forsblad-d'Elia H, Carlsten H, Labrie F, Konttinen YT, Ohlsson C.
    J Clin Endocrinol Metab; 2009 Jun; 94(6):2044-51. PubMed ID: 19318446
    [Abstract] [Full Text] [Related]

  • 28. The effects of oral dehydroepiandrosterone on endocrine-metabolic parameters in postmenopausal women.
    Mortola JF, Yen SS.
    J Clin Endocrinol Metab; 1990 Sep; 71(3):696-704. PubMed ID: 2144295
    [Abstract] [Full Text] [Related]

  • 29. The association of androgenic sex steroids with serum lipid levels in postmenopausal women.
    Noyan V, Yucel A, Sagsoz N.
    Acta Obstet Gynecol Scand; 2004 May; 83(5):487-90. PubMed ID: 15059164
    [Abstract] [Full Text] [Related]

  • 30. Effects of a 3-week dehydroepiandrosterone administration on sleep, sex steroids and multiple 24-h hormonal profiles in postmenopausal women: a pilot study.
    Caufriez A, Leproult R, L'Hermite-Balériaux M, Kerkhofs M, Copinschi G.
    Clin Endocrinol (Oxf); 2013 Nov; 79(5):716-24. PubMed ID: 23488643
    [Abstract] [Full Text] [Related]

  • 31. A randomized trial of oral DHEA treatment for sexual function, well-being, and menopausal symptoms in postmenopausal women with low libido.
    Panjari M, Bell RJ, Jane F, Wolfe R, Adams J, Morrow C, Davis SR.
    J Sex Med; 2009 Sep; 6(9):2579-90. PubMed ID: 19619146
    [Abstract] [Full Text] [Related]

  • 32. Cortisol, dehydroepiandrosterone (DHEA), and DHEA sulfate in the cerebrospinal fluid of man: relation to blood levels and the effects of age.
    Guazzo EP, Kirkpatrick PJ, Goodyer IM, Shiers HM, Herbert J.
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3951-60. PubMed ID: 8923843
    [Abstract] [Full Text] [Related]

  • 33. Effects of dehydroepiandrosterone replacement therapy on bone mineral density in older adults: a randomized, controlled trial.
    Jankowski CM, Gozansky WS, Schwartz RS, Dahl DJ, Kittelson JM, Scott SM, Van Pelt RE, Kohrt WM.
    J Clin Endocrinol Metab; 2006 Aug; 91(8):2986-93. PubMed ID: 16735495
    [Abstract] [Full Text] [Related]

  • 34. Antioxidant activity of dioscorea and dehydroepiandrosterone (DHEA) in older humans.
    Araghiniknam M, Chung S, Nelson-White T, Eskelson C, Watson RR.
    Life Sci; 1996 Aug; 59(11):PL147-57. PubMed ID: 8795709
    [Abstract] [Full Text] [Related]

  • 35. A randomized double-blinded placebo-controlled trial on the effect of dehydroepiandrosterone for 16 weeks on ovarian response markers in women with primary ovarian insufficiency.
    Yeung TW, Li RH, Lee VC, Ho PC, Ng EH.
    J Clin Endocrinol Metab; 2013 Jan; 98(1):380-8. PubMed ID: 23144466
    [Abstract] [Full Text] [Related]

  • 36. Effects of short-term DHEA intake on hormonal responses in young recreationally trained athletes: modulation by gender.
    Collomp K, Buisson C, Gravisse N, Belgherbi S, Labsy Z, Do MC, Gagey O, Dufay S, Vibarel-Rebot N, Audran M.
    Endocrine; 2018 Mar; 59(3):538-546. PubMed ID: 29322301
    [Abstract] [Full Text] [Related]

  • 37. [Adrenopause and dehydroepiandrosterone: pharmacological therapy versus replacement therapy].
    Römmler A.
    Gynakol Geburtshilfliche Rundsch; 2003 Apr; 43(2):79-90. PubMed ID: 12649580
    [Abstract] [Full Text] [Related]

  • 38. Biotransformation of oral dehydroepiandrosterone in elderly men: significant increase in circulating estrogens.
    Arlt W, Haas J, Callies F, Reincke M, Hübler D, Oettel M, Ernst M, Schulte HM, Allolio B.
    J Clin Endocrinol Metab; 1999 Jun; 84(6):2170-6. PubMed ID: 10372727
    [Abstract] [Full Text] [Related]

  • 39. Oral dehydroepiandrosterone for adrenal androgen replacement: pharmacokinetics and peripheral conversion to androgens and estrogens in young healthy females after dexamethasone suppression.
    Arlt W, Justl HG, Callies F, Reincke M, Hübler D, Oettel M, Ernst M, Schulte HM, Allolio B.
    J Clin Endocrinol Metab; 1998 Jun; 83(6):1928-34. PubMed ID: 9626121
    [Abstract] [Full Text] [Related]

  • 40. Long-term low-dose dehydroepiandrosterone oral supplementation in early and late postmenopausal women modulates endocrine parameters and synthesis of neuroactive steroids.
    Genazzani AD, Stomati M, Bernardi F, Pieri M, Rovati L, Genazzani AR.
    Fertil Steril; 2003 Dec; 80(6):1495-501. PubMed ID: 14667889
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.